PHARMACEUTICAL FORMULATIONS CONTAINING ANTI-OX40L ANTIBODIES

The present disclosure provides aqueous pharmaceutical formulations comprising anti-OX40L antibodies or antigen binding fragment thereof for treating or preventing OX40L-mediated diseases or conditions in humans. The present disclosure also provides containers and kits comprising the aqueous pharmac...

Full description

Saved in:
Bibliographic Details
Main Authors BADIALI, Luca, JERE, Dhananjay, PATKE, Sanket, ZHU, Chen, JÖRG, Susanne, ENGELKE, Laura, GUPTA, Ashi, GOODING, Tamera
Format Patent
LanguageEnglish
French
Published 17.10.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides aqueous pharmaceutical formulations comprising anti-OX40L antibodies or antigen binding fragment thereof for treating or preventing OX40L-mediated diseases or conditions in humans. The present disclosure also provides containers and kits comprising the aqueous pharmaceutical formulations and the use of these aqueous pharmaceutical formulations in treating or preventing OX40L-mediated diseases or conditions in humans. La présente divulgation concerne des formulations pharmaceutiques aqueuses comprenant des anticorps anti-OX40L ou un fragment de liaison à l'antigène de ceux-ci pour le traitement ou la prévention de maladies ou d'états à médiation par OX40L chez l'homme. La présente invention concerne également des récipients et des kits comprenant les formulations pharmaceutiques aqueuses et l'utilisation de ces formulations pharmaceutiques aqueuses dans le traitement ou la prévention de maladies ou d'états à médiation par OX40L chez l'homme.
Bibliography:Application Number: WO2024EP60094